ATAGI statement on the use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised
Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of a third primary dose of COVID-19 vaccine in individuals who are severely immunocompromised have been announced.
The recommendations have been outlined below:
- ATAGI recommends a 3rd dose of COVID-19 vaccine as part of the primary course in individuals who are severely immunocompromised.
- This is to address the risk of suboptimal or non-response to the standard 2 dose schedule.
- The 3rd dose is intended to maximise the level of immune response to as close as possible to the general population.
- This recommendation applies to all individuals aged ≥12 years with certain conditions or on therapies leading to severe immunocompromise, as defined in Box 1 (refer to full statement).
- An individual with an unlisted condition should only be considered for a 3rd dose where the treating physician has assessed the patient as having a similar level of severe immunocompromise to the listed conditions in Box 1, and where the benefits of a 3rd dose of COVID-19 vaccine outweigh the risks.
- Individuals who currently are not severely immunocompromised but who will commence significant immunosuppressive therapy ≥ 2 weeks after their 2रा dose do not require a 3rd dose, as it can be expected that an adequate response to 2 primary doses will be achieved.
- ATAGI does not recommend subsequent doses beyond the 3rd dose at this time. Many patients who fail to respond to 3rd doses may not respond to further doses.
- Protection from 3 primary doses in severely immunocompromised individuals may still be lower than the general population. People should continue risk mitigation strategies such as mask wearing and social distancing even after receipt of a 3rd dose.
- ATAGI will continue to monitor the evidence around duration of protection and advise on the need for subsequent (booster) doses in immunocompromised populations to address waning of protection or risk from variants of concern.
- ATAGI will provide further advice on booster doses (including for healthcare workers, older adults and the general population) separately. See about the need for additional doses of COVID-19 vaccines.
To view the statement in full, please click on the link below.
ATAGI statement on the use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised
WHO recommends groundbreaking malaria vaccine for children at risk
The World Health Organization (WHO) is recommending widespread use of the RTS,S/AS01 (RTS,S) malaria vaccine among children in sub-Saharan Africa and in other regions with moderate to high P. falciparum malaria transmission. The recommendation is based on results from an ongoing pilot programme in Ghana, Kenya and Malawi that has reached more than 800 000 children since 2019.
According to the WHO, malaria remains a primary cause of childhood illness and death in sub-Saharan Africa where more than 260 000 African children under the age of five die from malaria annually.
WHO Director-General Dr Tedros Adhanom Ghebreyesus commented “This is a historic moment. The long-awaited malaria vaccine for children is a breakthrough for science, child health and malaria control. Using this vaccine on top of existing tools to prevent malaria could save tens of thousands of young lives each year.”
WHO recommends that the RTS,S/AS01 malaria vaccine be used for the prevention of P. falciparum malaria in children living in regions with moderate to high transmission as defined by WHO. In addition to this, RTS,S/AS01 malaria vaccine should be provided in a schedule of 4 doses in children from 5 months of age for the reduction of malaria disease and burden.
To read the extract in full, please click on the link below:
WHO recommends groundbreaking malaria vaccine for children at risk
SMH: Separating reproductive health fact from COVID-19 vaccine fiction
Dr Daryl Cheng spoke to ABC journalist Sarah Berry regarding the increasing amount of misinformation circulating about COVID-19 vaccines and women’s health. Many of the rumours target women who are pregnant or planning a pregnancy and who are already experiencing anxiety about making the best choices for the health of their babies.
In this article, Dr Daryl Cheng provides scientific data-based insights on the vaccine’s effect on reproductive health. The data focuses on providing advice and information to help refute some persistent rumours regarding fertility, menstruation, and IVF treatments in women.
Follow this link to read the full article:
SMH: Separating reproductive health fact from COVID-19 vaccine fiction
The Conversation: Who can’t have a COVID vaccine and how do I get a medical exemption?
State and territory governments and businesses are currently in the process of establishing COVID-19 vaccine mandates across a range of sectors, including the Victorian government which mandated COVID vaccination for all authorised workers last week. Despite this necessary step, there is still a very small amount of people who are unable to receive a COVID-19 vaccine for medical reasons. ATAGI has released guidelines on which instances an individual may be granted a medical exception.
The only criteria for a permanent exception are due to anaphylaxis following a previous COVID-19 vaccine dose or to any component of a vaccine.
Temporary exceptions may be approved for some “acute major medical illnesses” where the COVID vaccine can be deferred for a certain amount of time.
COVID vaccine exceptions can be administered by general practitioners, paediatricians, clinical immunologists, infectious disease, general or public health physicians, gynaecologists, or obstetricians. As vaccine mandates continue to be implemented, it’s crucial for employers, individuals, and medical providers to stay up to date with new ATAGI clinical guidance regarding the medical exemption criteria.
Click the link to read the full article:
The Conversation: Who can’t have a COVID vaccine and how do I get a medical exemption?
Save the date for our virtual Clinical Vaccinology Update (CVU)!
MVEC are pleased to announce we will be hosting a virtual Clinical Vaccinology Update (CVU) on Thursday 18 and Friday 19 November, 2021.
कार्यक्रम विवरण और टिकट की जानकारी शीघ्र ही हमारे माध्यम से घोषित की जाएगी MVEC Events Page.
आयु: फाइजर और मॉडर्ना कोविड टीके अब 60 वर्ष से अधिक आयु के सभी ऑस्ट्रेलियाई लोगों के लिए उपलब्ध हैं
स्वास्थ्य मंत्री ग्रेग हंट ने घोषणा की है कि शुक्रवार, 1 अक्टूबर से 60 और उससे अधिक आयु के ऑस्ट्रेलियाई फाइजर और मॉडर्न प्राप्त करने में सक्षम होंगे, भले ही वे कहीं भी रहते हों, 300,000 से अधिक वृद्ध लोगों के लिए वैक्सीन विकल्प का विस्तार करना, जो टीका लगवाने की प्रतीक्षा कर रहे हैं।
इसके अलावा, यह भी घोषणा की गई है कि विक्टोरिया को 60 वर्ष से कम उम्र के लोगों पर ध्यान केंद्रित करने के लिए राज्य के क्लीनिकों में सहायता के लिए अतिरिक्त 88,900 मॉडर्ना खुराक प्राप्त होगी, जबकि जीपी और फार्मेसियां उन 60 और उससे अधिक के टीकाकरण पर ध्यान केंद्रित करेंगी।
लेख को पूरा पढ़ने के लिए कृपया नीचे दिए गए लिंक पर क्लिक करें:
आयु: फाइजर और मॉडर्ना कोविड टीके अब 60 वर्ष से अधिक आयु के सभी ऑस्ट्रेलियाई लोगों के लिए उपलब्ध हैं
Victorian Government COVID-19 Vaccination Enhancement Grants
The Victorian Government is offering COVID-19 Vaccination Enhancement Grants to pharmacies and general practices interested in maximising their capacity to deliver vaccines across identified geographic areas at higher risk of COVID-19.
The grants are designed to support primary care providers to utilise their full vaccine allocations and to confidently promote access in their local communities as well as fund additional workforce or operational costs associated with maximising COVID-19 vaccine administration.
To find out more information about the grants available, please click on the link below.
Victorian Government COVID-19 Vaccination Enhancement Grants
मॉडर्न फार्मेसी अपॉइंटमेंट ऑनलाइन बुकिंग प्लेटफॉर्म के माध्यम से उपलब्ध है
जैसे ही सामुदायिक फ़ार्मेसी देश भर में मॉडर्न वैक्सीन का प्रबंध करना शुरू करती हैं, नीचे सूचीबद्ध दो बुकिंग प्लेटफ़ॉर्म हैं जो आपकी निकटतम सामुदायिक फ़ार्मेसी का पता लगाने और वैक्सीन नियुक्ति के लिए उनकी उपलब्धता में सहायता कर सकते हैं।
एमवीईसी साइटों से संबद्ध नहीं हैं और जानकारी को केवल एक गाइड के रूप में इस्तेमाल किया जाना चाहिए।
आप नीचे दिए गए लिंक के माध्यम से बुकिंग प्लेटफॉर्म देख सकते हैं।
एक फार्मेसी खोजें
Covid19नियरमी
Healthed lecture series featuring Associate Professor Nigel Crawford
MVEC’s Associate Professor Nigel Crawford delivered the COVID-19 Update as part of the recent Healthed Australia online lecture series.
In this lecture, A/Prof Nigel Crawford discussed the following:
- An update on the latest ATAGI announcements
- Moderna safety data
- The booster debate
- Back to school
To listen to the lecture in full, click on the link below:
Healthed lecture series 28 September: COVID-19 Update
New immunisation reference page: COVID-19 mandatory vaccination directions in Victoria
Due to the potential for high levels of disease transmission and an increased risk of severe disease in vulnerable groups, COVID-19 vaccination has been made mandatory for specific workplaces/industries within Victoria.
Our new reference page outlines the current COVID-19 Mandatory Vaccination Directions Order in place in Victoria, including an overview of the responsibilities for both employers and employees, as well as information regarding the medical exemptions for COVID-19 vaccines.
अधिक पढ़ने के लिए नीचे दिए गए लिंक का अनुसरण करें:
एमवीईसी: विक्टोरिया में कोविड-19 अनिवार्य टीकाकरण निर्देश